Mark Berger
Chief Tech/Sci/R&D Officer at GENPREX, INC.
Net worth: 14 322 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Varner | M | 67 | 15 years | |
| Harlan Waksal | M | 71 |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 10 years |
| Kalyn Dabbs | M | - | 5 years | |
| Avinash Desai | M | - | 4 years | |
| William Wilson | M | 74 | 4 years | |
| Jose Antonio Moreno Toscano | M | 51 | 4 years | |
| Jeffrey Chell | M | 70 | 6 years | |
| Ajit Shetty | M | 77 | 7 years | |
| Brent Longnecker | M | 67 | 4 years | |
| Bart M. Schwartz | M | 77 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 9 years |
| Richard M. Stone | M | - | 7 years | |
| Ryan Confer | M | 42 | 15 years | |
| Thomas C. Gallagher | M | - | 4 years | |
| David Schloss | M | 65 | 4 years | |
| Anastasios Konidaris | M | 57 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 7 years |
| Mary Mei Chen | M | - | 4 years | |
| Paul Diamond | M | - | 3 years | |
| Celina Laney | F | - | 6 years | |
| Greg Jancarik | M | - | 3 years | |
| Kate Combs | F | - | 3 years | |
| Suzanne Thornton-Jones | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sergio Traversa | M | 63 | 4 years | |
| Kaushik J. Dave | M | 63 | 4 years | |
| Julien Pham | M | 47 | 4 years | |
| Dragan Cicic | M | 60 | 12 years | |
| Moncef Slaoui | M | 64 | 11 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| David E. Friedman | M | 60 | 8 years | |
| Michèle Barzach | M | - | 7 years | |
| John David Coombe | M | 79 | 5 years | |
| Christopher Gent | M | 75 | 11 years | |
| Robert Wilson | M | 81 | 11 years | |
| Daniel Podolsky | M | 70 | 10 years | |
| Samuel D. Waksal | M | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | - |
| Patrick J. T. Vallance | M | 64 | - | |
| Crispin Davis | M | 75 | 10 years | |
| Tom de Swaan | M | 78 | 9 years | |
| H. Culp | M | 60 | 9 years | |
| Robert Pearson | M | 61 | 8 years | |
| Alex Howarth | M | 55 | 10 years | |
| Peter Traber | M | 69 | 3 years | |
| Catherine Vaczy | F | 62 | 5 years | |
| Alasdair B. James | M | 53 | 6 years | |
| Vincent O'Neill | M | 55 | 3 years | |
| Michael Allen Luther | M | 67 | 15 years | |
| Eva Heyman | F | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | - |
| James Wu | M | - | 10 years | |
| John Clarke | M | - | - | |
| David Wheadon | M | 66 | 5 years | |
| Bing Li | M | 55 | 4 years | |
| Manuel Alves Aivado | M | 53 | 6 years | |
| Stewart Mccallum | M | 58 | 9 years | |
| Lisa Bright | F | 56 | 17 years | |
| Johan Heylen | M | 56 | 4 years | |
| Brian Blakey | M | 61 | 6 years | |
| Vivid Sehgal | M | 56 | 6 years | |
| Neil Brewis | M | 57 | 8 years | |
| Elizabeth Han | F | - | 2 years | |
| David Gordon | M | 55 | 11 years | |
| Vijay Reddy | M | - | 4 years | |
| Myra Rosario Herrle | M | - | 9 years | |
| Joe McCann | M | 47 | 4 years | |
| Chao Hong Hu | M | 58 | 1 years | |
| Jing Ji | M | 54 | 4 years | |
| Hemant Kumar | M | 61 | 2 years | |
| Robert Copeland | M | - | - | |
| Tonya Williams | F | 50 | 1 years | |
| Zhen Ping Zhu | M | 59 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 6 years |
| Jean Viallet | M | 66 |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | 9 years |
| Gill Dines | F | - | - | |
| Dan A. Giampuzzi | M | - |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | 9 years |
| Fred Banti | M | 67 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | 2 years |
| Joseph M. Spagnardi | M | 60 | 11 years | |
| Michael D. Rogers | M | 68 | 6 years | |
| Paul A. Allaire | M | - | - | |
| Donald F. McHenry | M | 87 | - | |
| John Hector McArthur | M | 90 | - | |
| Timothy Barberich | M | 76 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | 4 years |
| Howard H. Pien | M | 66 | 12 years | |
| John N. Bonfiglio | M | 69 | - | |
| F. Roger Hurn | M | 86 | - | |
| Christopher Anthony Hogg | M | - | - | |
| Lucy Shapiro | M | 83 | 5 years | |
| Stephen A. Ross | M | 54 | 5 years | |
| Lisa E. Porter | M | 60 | 5 years | |
| Denis Brodsky | M | 53 | 5 years | |
| Jennie Younger | F | - | 5 years | |
| John B. Ziegler | M | 78 | - | |
| Douglas B. Snyder | M | 60 | 6 years | |
| Jeff Baxter | M | 62 | 4 years | |
| Atul Pande | M | 69 | 7 years | |
| Eric Roberts | M | 59 |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | 4 years |
| Marc Rubin | M | 69 | 13 years | |
| Paul Carter | M | 63 | 10 years | |
| Lauren Flanagan | F | - | - | |
| Janice Stevens | F | - | 1 years | |
| Sheng Da Zan | M | 61 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | - |
| Anil Kapur | M | 54 | 1 years | |
| Robert J. DiVasto | M | 68 | 2 years | |
| K Fletcher | M | - |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 56 | 56.00% |
| United States | 24 | 24.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Berger
- Personal Network
